M. Aoun
Impact in
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing
- Infectious Diseases top 2%
- Antifungal resistance and susceptibility
Papers in ⓘ
-
- Bacterial Identification and Susceptibility Testing 9
-
- Antifungal resistance and susceptibility 9
- Co-authors
- Jean Klášterský (9 shared papers)Johan Maertens (2 shared papers)Aspasia Georgala (5 shared papers)F. Muanza (2 shared papers)Emilio Bouza (2 shared papers)F. Meunier (5 shared papers)Bernardo L. Rapoport (1 shared paper)C. Rieger (1 shared paper)
- Journals
- International Journal of Antimicrobial Agents (4 papers)Supportive Care in Cancer (4 papers)Clinical Infectious Diseases (3 papers)Clinical Microbiology and Infection (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- BelgiumLebanonUnited States
In The Last Decade
M. Aoun
33 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Clinical Biochemistry 378
- Infectious Diseases 810
- Epidemiology 822
- Oncology 605
- Emergency Medicine 165
Countries citing papers authored by M. Aoun
This map shows the geographic impact of M. Aoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Aoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Aoun more than expected).
Fields of papers citing papers by M. Aoun
This network shows the impact of papers produced by M. Aoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Aoun. The network helps show where M. Aoun may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Aoun, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High-Loading Dose Regimen with Standard Dosing (AmBiLoad Trial) Hit paper breakdown → | 2007 | 486 |
| 2 | 2007 | 243 | |
| 3 | 2006 | 223 | |
| 4 | 2006 | 119 | |
| 5 | 2004 | 73 | |
| 6 | 2004 | 59 | |
| 7 | 2004 | 52 | |
| 8 | 1993 | 49 | |
| 9 | 1991 | 48 | |
| 10 | 1992 | 25 | |
| 11 | 2004 | 24 | |
| 12 | 2003 | 24 | |
| 13 | 1992 | 19 | |
| 14 | 2011 | 18 | |
| 15 | 2003 | 16 | |
| 16 | 2016 | 16 | |
| 17 | 1993 | 10 | |
| 18 | 2000 | 10 | |
| 19 | 1991 | 10 | |
| 20 | 2023 | 8 |
About M. Aoun
M. Aoun is a scholar working on Clinical Biochemistry, Infectious Diseases, Molecular Medicine, Endocrinology and Critical Care and Intensive Care Medicine, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (10 papers), Bacterial Identification and Susceptibility Testing (9 papers), Antifungal resistance and susceptibility (9 papers), Fungal Infections and Studies (7 papers), Hematological disorders and diagnostics (3 papers), Antibiotic Resistance in Bacteria (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Clinical Biochemistry (378 citations), Infectious Diseases (810 citations), Epidemiology (822 citations), Oncology (605 citations) and Emergency Medicine (165 citations). M. Aoun has collaborated with scholars based in Belgium, Lebanon and United States. Frequent co-authors include Jean Klášterský, Johan Maertens, Aspasia Georgala, F. Muanza, Emilio Bouza, F. Meunier, Bernardo L. Rapoport, C. Rieger, K. V. I. Rolston and Dietmar Reichert. Their work appears in journals such as International Journal of Antimicrobial Agents, Supportive Care in Cancer, Clinical Infectious Diseases, Clinical Microbiology and Infection and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.